If you require in person training, please send a request, to include a daytime telephone number, to your Startright team at firstname.lastname@example.org
|Guardian™ Connect CGM Compatible Devices|
|iOS*||11.4, 11.4.1, 12.0, 12.1, 12.2, 12.3, 13.0, 13.1, 13.2, 13.3, 13.5.1, 13.6, 14.0, 14.2, 14.3, 14.4, 14.5, 14.6, 15.0, 15.1, 15.2, 15.3|
|iPhone||5s, 6, 6+, 6s, 6s Plus, SE, 7, 7 Plus, 8, 8 Plus, X, XS, XS Max, XR, 11, 11 Pro, 11 Pro Max, iPhone SE (2nd Gen 2020), iPhone 12, iPhone 12 mini, iPhone 12 Pro, iPhone 12 Pro Max, iPhone 13, iPhone 13 mini, iPhone 13 Pro, iPhone 13 Pro Max|
|iPod Touch||6th Generation, 7th Generation|
|iPad||5.6, Air, Air 2, Mini 2, Mini 3, Mini 4, Pro (9.7"), Pro (10.5"), Pro (12.9"), Pro 2 (12.9")|
*13.7 compatibility is pending
The Guardian™ Connect Continuous Glucose Monitoring System (CGM) is Medtronic’s only system in the world that gives you insights and helps protect against lows and highs up to 60 minutes in advance!
The Guardian™ Connect System measures your glucose levels every 5 minutes, 24hrs a day, giving you up to 288 readings a day! The Guardian™ Connect also uses smart technology to predict when you are trending low or high. The system consists of 3 parts – a sensor (the Guardian™ Sensor (3), a transmitter (The Guardian™ Link (3)) and an Apple (iOS) enabled device, please see below for compatibility.
The Guardian™ Connect System has the unique ability to provide advanced or predictive readings of a high or low up to 60 minutes ahead of time. When you have the power to predict your glucose levels, you have the power to take action so you can confidently focus on your life, not your readings.
The Guardian™ Connect has lots of exciting new features. Let’s highlight three of the main features:
The Guardian™ Connect CGM System gives you advanced warnings of a high or low 60 minutes in advance.
What would you do with 60 minutes advanced knowledge of your readings? Go to your child’s soccer game without worrying about their blood sugar? Maybe be ready for that important meeting? How about going out to dinner with friends and knowing where your blood sugar is at all times.
Whatever you have on the go, the Guardian™ Connect CGM System gives you the confidence to focus on your life and not your readings.
Let your family and friends know you are okay by giving them access to your readings. If their device is connected to the internet, they will be able to get your readings at any time. With our unique CareLink™ Connect platform, whether you have a desktop computer, cell phone or tablet, the Guardian™ Connect system gives your loved ones’ peace of mind knowing you are within range.
No more manual CareLink uploads! The Guardian™ Connect CGM System has a unique bluetooth feature. It allows for automatic uploads to CareLink™ every 24 hours giving you and your health care provider easy access to your data.
Over 80% of people that apply for insurance coverage are approved. We can help you inquire and apply for insurance coverage through our dedicated Guardian™ Connect sales consultant. Contact us at 1.800.284.4416.
If you are familiar with CGM systems and are looking to purchase one for yourself, visit shop.medtronicdiabetes.ca. You can purchase it directly from there.
If you are currently using a MiniMed™ 670G, another CGM or FGM platform, or want to explore your options using the New Guardian™ Connect CGM System, please call 1.800.284.4416 and our Guardian™ Connect Sales Consultant will be able to help answer all of your questions.
The Guardian™ Connect CGM System is warranted for 12 months from the date of purchase. Since the battery is rechargeable there is no need to replace it every couple of months. The Guardian™ Connect CGM Systems shows your battery level on your phone so you don’t have to worry about the battery dying. When you replace the sensor, simply put the transmitter on the charger. A charge of 20 minutes will allow you to charge the transmitter to 100% giving you ample battery for the life for your sensor.
The Guardian™ Connect System is currently only compatible with iOS compatible devices.
The warning message is there to indicate that the current system has not yet been fully tested or supported. While we cannot guarantee full app functionality until the release has been fully tested, clicking out of the warning message will enable the app to work. The warning message will not appear once we have fully tested the new app version. In the meantime, if you do experience any issues, please report them through our 24 Hour Technical Support Line.
We recommend that you check our full compatibility list before updating your operating system. If it is not listed as compatible, we recommend not updating your operating system until we have tested and ensured full compatibility.
We are working with Apple to test beta versions as soon as they become available, in order to ensure full compatibility as soon as possible. However, if we discover the new operating system has caused a change to the intended behavior of the Guardian™ Connect app, then it may take additional time to ensure that the app fully functions as intended with the new operating system.
The Guardian™ Connect App is intended for monitoring glucose levels in the interstitial fluid under the skin, in persons aged 3 years or older with diabetes mellitus.
a) Do not use the Guardian™ Connect System for pediatric patients until you have thoroughly reviewed (with your Healthcare Professional), the system alert performance in the Guardian™ Connect Application User Guide and the sensor accuracy performance in the Guardian™ Sensor (3) Performance document. Discuss with your Healthcare Professional how to best set up your Guardian Connect System alerts to reduce the risk of missing low blood glucose or high blood glucose events.
b) In the pediatric clinical study (3-18 years of age), larger differences were observed between the Guardian™ Connect System and actual blood glucose values compared to those differences observed in the adolescent/adult clinical study (14-75 years of age), particularly at low glucose levels.
c) In the pediatric clinical study, a significant percentage of low glucose events were not detected by the Guardian™ Connect System. Do not rely solely on the Guardian™ Connect System alerts to detect low glucose.
d) In the pediatric clinical study, the Guardian™ Connect System triggered a high percentage of false low glucose and false high glucose alerts. The Guardian™ Connect System is not intended to make therapy adjustments: always check your capillary blood glucose before making therapy adjustments.
e) In the pediatric clinical study, enabling the ‘Alert Before Low’ and ‘Alert Before High’ predicted alerts significantly reduced the percentage of missed low blood glucose and missed high blood glucose events, but also significantly increased the percentage of false low glucose and false high glucose alerts. Do not ignore alerts from your Guardian™ Connect System. Always follow your treatment instructions from your Healthcare Professional when responding to an alert from your Guardian™ Connect System.